openPR Logo
Press release

Asia-Pacific Generic Drugs Market 2021: Top Industry Players, Growth Report to 2027

05-28-2021 01:58 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Asia-Pacific generic drugs market is estimated to grow at a CAGR of nearly 8.0% during the forecast period. A significant rise in the prevalence of chronic diseases is the major factor accelerating the demand for generic medicines in the region. As per the estimation by the World Health Organization (WHO), the number of new cancer incidences expected to be reported in china was nearly 4.6 million in 2020. Further, the National Cancer Registry Programme estimates that there will be 13.9 lakh new cancer incidences reported in India in 2020, which is expected to rise to 15.7 lakh by 2025.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-generic-drugs-market

This, in turn, is leading to increasing demand for generic drugs in these countries. Cost is the major benefit associated with the use of generic drugs. The cost of generic drugs can be up to 85% lower compared to the brand-name drug. Generic drug firms do not have to invest in high initial drug development costs which results in the low cost of these drugs compared to branded drugs. The low cost of generics is acting as a major factor accelerating market growth.

A Full Report of Asia-Pacific Generic Drugs Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-generic-drugs-market

Scope of the Asia-Pacific Generic Drugs Market

Market Coverage

Market number available for 2019-2026
Base year- 2019
Forecast period- 2020-2026
Segment Covered- By Application and Route of Administration
Regions Covered- China, India, Japan, and Rest of Asia-Pacific
Competitive Landscape- Mylan N.V., Teva Pharmaceutical Industries Ltd., Lupin Ltd., Aurobindo Pharma Ltd., and Sun Pharmaceutical Industries Ltd.

Recent Strategic Initiatives in the Asia-Pacific Generic Drugs Market

In July 2020, Cipla declared the launch of its generic version of antiviral drug remdesivir, Cipremi, at $53.3 per 100 mg vial. This makes it among the lowest cost versions for COVID-19 treatment and Cipla is looking to deliver more than 80,000 vials within the first month.
In July 2020, Mylan launched a generic version of Remdesivir drug, Desrem, in India for treatment of COVID-19 patients. This drug will be available at a price of nearly $64.2 per 100 mg vial as against Hetero’s Covifor at nearly 72.2 per 100 mg vial and Cipla’s Cipremi costing nearly $53.3 per 100 mg vial.

Asia-Pacific Generic Drugs Market-Segmentation

By Application

Cancer
CVD
Musculoskeletal Diseases
Infectious Diseases
Neurology
Diabetes
Others

By Route of Administration

Oral
Topical
Injectable
Inhaler

Asia-Pacific Generic Drugs Market– Segment by Country

China
Japan
India
Rest of Asia-Pacific

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-generic-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Generic Drugs Market 2021: Top Industry Players, Growth Report to 2027 here

News-ID: 2293191 • Views:

More Releases from Orion Market Research

Liquid Soap Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2031 | Colgate-Palmolive Co., GOJO Industries, Inc., Ivory, LION Corp., Procter & Gamble
Liquid Soap Market is Likely to Increase at a Significantly High CAGR during For …
The global liquid soap market is anticipated to grow at a considerable CAGR of around 9.8% during the forecast period. Various governments in different countries are launching programs and promotions regarding personal hygiene and cleanliness such as hygiene maintenance in a public toilet, hand washing among children and more are the reason to augment the market and increase in demand for personal care products. In January 2021, Japan International Cooperation
Laundry Detergent Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ Clorox, Hindustan Unilever Ltd., Procter & Gamble GmbH, Reckitt Benckiser group
Laundry Detergent Market Increasing Demand, Growth Analysis and Future Outlook b …
The global laundry detergent market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period. The growing demand for laundry detergents has been observed in the commercial sector, significantly, owing to the rise in the small business sectors such as restaurants, salons, clinics, laundry services, and others who use clothes during their working hours. Moreover, post-COVID-19 pandemic, several such businesses have increased their concern towards sanitizing
Stem Cell Therapy Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Stem Cell Therapy Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global stem cell therapy market is anticipated to grow at a CAGR of 15.8% during the forecast period. The ongoing developments in stem cell therapy are key factors driving the growth of the global stem cell therapy market. For instance, in July 2022, the Louisville-based National Stem Cell Foundation (NSCF) funded the first-in-kind study of neurodegeneration on the International Space Station (ISS) with a bi-coastal team of leading experts
Rabies Immunoglobulin Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Rabies Immunoglobulin Market Size, Trends, Latest Insights, Analysis and Forecas …
The global rabies immunoglobulin market is anticipated to grow at a CAGR of 6.1% during the forecast period. As a zoonotic disease, it requires close cross-sectoral coordination at the national, regional, and global levels. The rising government initiatives in the market are expected to surge the market growth during the forecast period. Rabies is included in WHO's new 2021-2030 road map. The 2030 NTD Roadmap is a guiding document for

All 5 Releases


More Releases for Generic

Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs. The global generic drugs market is driven by the rise of
Generic Wellness Offers Special Discount on Generic Xenical for Fat Reduction !
This week a special offer is introduced by Generic Wellness for weight loss treatment with an oral drug called generic Xenical. The drug is an excellent weight loss treatment for all men and women above the age of 12. People who have taken this drug for weight loss have actually experienced the benefits like reduction of unwanted fat in the body. This is possible with generic Xenical because of the
Generic Drugs Market Trends 2025
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Generic Drugs Market - Global Competitive Analysis
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by